Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Sureda, Anna
[Clear All Filters]
2020
Berro M
,
Chhabra S
,
Piñana JLuis
,
Arbelbide J
,
Rivas MM
,
Basquiera ALisa
,
Vitriu A
,
Requejo A
,
Milovic V
,
Yantorno S
, et al.
Predicting mortality after autologous transplant: Development of a novel risk score.
Biol Blood Marrow Transplant. 2020.
PubMed
Google Scholar
Piñana JLuis
,
Martino R
,
García-García I
,
Parody R
,
Morales MDolores
,
Benzo G
,
Gómez-Catalan I
,
Coll R
,
De La Fuente I
,
Luna A
, et al.
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
Exp Hematol Oncol. 2020;9:21.
PubMed
Google Scholar
2019
Bazarbachi A
,
Boumendil A
,
Finel H
,
Castagna L
,
Dominietto A
,
Blaise D
,
Diez-Martin JL
,
Tischer J
,
Gulbas Z
,
Wallet HL
, et al.
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.
Br J Haematol. 2019.
PubMed
Google Scholar
2018
Bazarbachi A
,
Boumendil A
,
Finel H
,
Mohty M
,
Castagna L
,
Blaise D
,
Peggs KS
,
Afanasyev B
,
Díez-Martín JL
,
Corradini P
, et al.
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer. 2018.
PubMed
Google Scholar
2016
van Gorkom G
,
Finel H
,
Giebel S
,
Pohlreich D
,
Shimoni A
,
Ringhoffer M
,
Sucak G
,
Schaap N
,
Dreger P
,
Sureda A
, et al.
Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.
J Clin Apher. 2016.
PubMed
Google Scholar
2015
Moskowitz CH
,
Nademanee A
,
Masszi T
,
Agura E
,
Holowiecki J
,
Abidi MH
,
Chen AI
,
Stiff P
,
Gianni AM
,
Carella A
, et al.
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2015.
PubMed
Google Scholar
2013
Smith SM
,
Burns LJ
,
van Besien K
,
Lerademacher J
,
He W
,
Fenske TS
,
Suzuki R
,
Hsu JW
,
Schouten HC
,
Hale GA
, et al.
Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma.
J Clin Oncol. 2013.
PubMed
Google Scholar
Pages
« first
‹ previous
1
2